LDR brachytherapy of "low risk" prostate cancer: Update of the 5-year experience in 118 patients

被引：0
作者：
Block, T.
Zimmermann, F.
Czempiel, H.
机构：
[1] Urol Praxis, Vaterstetten, Germany
[2] Tech Univ Munich, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2007年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [21] Treatment and 5-Year Survival in Patients With Nonmetastatic Prostate Cancer: The Norwegian Experience EDITORIAL COMMENT
    Prasad, Sandip M.
    Sartor, A. Oliver
    Bennett, Charles L.
    UROLOGY, 2014, 83 (01) : 152 - 153
  • [22] Early prostate cancer:: LDR prostate brachytherapy with 125I permanent implantation;: Experience at CROB
    Cocco, G.
    Iadanza, L.
    Zucca, S.
    Castaldo, G.
    Lapadula, L.
    Montagna, A.
    Mazziotta, M.
    Imbriani, E.
    Silvestre, G.
    Fusco, V
    ANNALS OF ONCOLOGY, 2006, 17 : XI80 - XI80
  • [23] Low-dose rate brachytherapy with I-125 seeds has an excellent 5-year outcome with few side effects in patients with low-risk prostate cancer
    Rasmusson, Elisabeth
    Gunnlaugsson, Adalsteinn
    Kjellen, Elisabeth
    Nilsson, Per
    Einarsdottir, Margret
    Wieslander, Elinore
    Fransson, Per
    Ahlgen, Goran
    Blom, Rene
    ACTA ONCOLOGICA, 2016, 55 (08) : 1016 - 1021
  • [24] LDR BRACHYTHERAPY WITH SEEDS AS MONOTHERAPY IN EARLY PROSTATE CANCER - THE LUND-MALMO EXPERIENCE THE 100 FIRST PATIENTS
    Einarsdottir, M.
    Blom, R.
    Bratt, O.
    Ahlgren, G.
    Leek, H.
    Lamm, I. L.
    Wieslander, E.
    af Rosenschold, P. Munck
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S333 - S333
  • [25] Nocturnal home haemodialysis: an update on a 5-year experience
    Pierratos, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (12) : 2835 - 2840
  • [26] Ten-year outcomes using low dose rate brachytherapy for localised prostate cancer: An update to the first Australian experience
    Wilson, Craig
    Waterhouse, David
    Lane, Stephen E.
    Haworth, Annette
    Stanley, John
    Shannon, Tom
    Joseph, David
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2016, 60 (04) : 531 - 538
  • [27] Biochemical outcome following interstitial low dose rate (LDR) prostate brachytherapy in intermediate and high risk patients
    Khaksar, S.
    Sooriakumaran, P.
    Henderson, A.
    Langley, S.
    Laing, R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 241 - 242
  • [28] Biochemical Control and Toxicity Outcomes of SBRT vs LDR Brachytherapy in the Treatment of Low and Intermediate Risk Prostate Cancer
    Gogineni, E.
    Rana, Z. H.
    Cai, H.
    Soberman, D.
    D'Andrea, V.
    Lee, L.
    Potters, L.
    Parashar, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E862 - E862
  • [29] COLORECTAL-CANCER - 58 PATIENTS, A 5-YEAR EXPERIENCE
    DENER, C
    TUMER, AR
    SAHIN, M
    KAMA, NA
    BRITISH JOURNAL OF SURGERY, 1995, 82 : 25 - 26
  • [30] LDR versus HDR brachytherapy boost in prostate cancer patients - a retrospective analysis
    Rodda, S.
    Murray, L.
    Bottomley, D.
    Bownes, P.
    Wilkinson, C.
    Adiotomre, E.
    Al-Qaisieh, B.
    Dugdale, E.
    Hulson, O.
    Mason, J.
    Smith, J.
    Henry, A. M.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S587 - S587
12345